(Q33950299)

30 July 2017

1 reference

title

Eicosanoids and the liver. (English)

1 reference

30 July 2017

Tolman KG

1

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Prostaglandins and Other Lipid Mediators

30 July 2017

published in

1 reference

30 July 2017

volume

61

1 reference

30 July 2017

issue

3-4

1 reference

30 July 2017

page(s)

163-174

1 reference

Eicosanoids, signal molecules of liver cells

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Studies on the mechanism of the protective action of 16,16-dimethylPGE2 in carbon tetrachloride induced acute hepatic injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Leukotriene-mediated liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Leukotrienes as mediators in frog virus 3-induced hepatitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Prostaglandins in liver failure and transplantation: regeneration, immunomodulation, and cytoprotection. Prostaglandins in Liver Transplantation Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Liver cytoprotection by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Inhibition of cyclo-oxygenase and lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Formation and actions of leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Isolation and culture of Kupffer cells from human liver. Ultrastructure, endocytosis and prostaglandin synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Synthesis of prostanoids and cyclic nucleotides by phagocytosing rat Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Mechanism of protective effect of prostaglandin E in murine hepatitis virus strain 3 infection: effects on macrophage production of tumour necrosis factor, procoagulant activity and leukotriene B4.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Effect of OKY-046 and ONO-3708 on liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

The role of thromboxane A2 [TxA2] in liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Hepatic tissue oxygenation as a predictive indicator of ischemia-reperfusion liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Contribution of No-reflow phenomenon to hepatic injury after ischemia-reperfusion: Evidence for a role for superoxide anion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Effect of PGI2 and thromboxane antagonist on liver ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Treatment of fulminant hepatic failure with intravenous prostaglandin E1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Prostaglandin-induced choleresis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

The effect of prostaglandin A1 and E1 on canine hepatic bile flow

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Prostaglandin E inhibits the production of human interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

The immunosuppressive properties of new oral prostaglandin E1 analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

Regulation of the proliferation of primary rat hepatocytes by eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900070-8

7 January 2021

10.1016/S0090-6980(00)00070-8

Identifiers

DOI

1 reference

30 July 2017

1 reference